Jacobson Pharma Corporation Limited
Research Jacobson Pharma Corporation Limited (2633.HK) on Bullrun: market cap HKD 1.92B, P/E 6.4, dividend yield 9.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2633.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 1.92B
- P/E6.4
- Dividend yield9.4%
- Financial periodFY2026
- RevenueHKD 1.57B
- Revenue growth-0.5%
- Net incomeHKD 301.62M
- Free cash flowHKD 192.20M
- Gross margin43.2%
Valuation Snapshot
latest market cap is HKD 1.92B; P/E is 6.4; dividend yield is 9.4%.
Peer valuation comparison
Latest P/E is 6.4x versus a Healthcare sector median of 21.69x (70.5% below).
Latest dividend yield is 9.42% versus a Healthcare sector median of 2.41% (290.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | HKD 1.57B | HKD 301.62M | HKD 192.20M | 43.2% | n/a | HKD 369.86M | HKD 910.90M | HKD 2.32B |
| FY2025 | HKD 1.58B | HKD 300.83M | HKD 278.39M | 43.9% | 0.15 | HKD 509.05M | HKD 773.21M | HKD 2.45B |
| FY2024 | HKD 1.47B | HKD 266.97M | HKD 354.85M | 42.3% | 0.14 | HKD 411.94M | HKD 749.38M | HKD 2.37B |
| FY2023 | HKD 1.27B | HKD 251.04M | HKD 567.09M | 42.5% | 0.13 | HKD 1.04B | HKD 1.60B | HKD 2.74B |
| FY2022 | n/a | n/a | n/a | n/a | 0.09 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.92B | 6.4 | 9.9% | 0.1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.1 HKD, yield 9.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.05 HKD |
| FY2025 | 0.19 HKD |
| FY2024 | 0.03 HKD |
| FY2023 | 0.05 HKD |
| FY2022 | 0.05 HKD |
About Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Jacobson Pharma Corporation Limited's market cap?
Jacobson Pharma Corporation Limited's market capitalization is HKD 1.92B.
What is Jacobson Pharma Corporation Limited's P/E ratio?
Jacobson Pharma Corporation Limited's price-to-earnings (P/E) ratio is 6.4.
Does Jacobson Pharma Corporation Limited pay a dividend?
Jacobson Pharma Corporation Limited has a dividend yield of 9.4%.
What does Jacobson Pharma Corporation Limited do?
Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally. The company offers a portfolio of generic drugs for various therapeutic classes, such as cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatologicals, and anti-allergics in oral solid and liquid, external liquid, semi-solid, sterile, rectal, and specialized forms.